Randomized phase III study comparing re-irradiation stereotactic body radiotherapy and conventional radiotherapy for painful spinal metastases: Japan Clinical Oncology Group study JCOG2211 (RESCORE study)
Japanese Journal of Clinical Oncology · 2025
DOI: 10.1093/jjco/hyae145 ↗Kurz gefasst
Fachartikel in der Zeitschrift Japanese Journal of Clinical Oncology, 2025. Verfasst von Ryosuke Kita und 11 weiteren Autor:innen. Beteiligte Einrichtung: Japan Clinical Oncology Group Data Center/Operations Office, National Cancer Center Hospital, Tokyo, Japan. Hauptthemen laut MEDLINE: Cancer Pain, Radiosurgery, Re-Irradiation, Spinal Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: National Cancer Center Research and Development Funds.
Abstract (Originalsprache)
Bone metastases are often associated with pain and can occur in various types of cancer, significantly affecting patients’ quality of life. Despite the high response rates to initial conventional radiotherapy in patients with painful spinal metastases, recurrence and inadequate response still occur. Thus, the development of a highly effective strategy for pain recurrence is crucial to improving the quality of life in patients with advanced metastatic cancer. This randomized phase III trial aims to confirm the superiority of re-irradiation with stereotactic body radiotherapy (24 Gy in 2 fractions) over conventional radiotherapy (8 Gy in a single fraction) in achieving a complete pain response at 12 weeks in patients with previously irradiated painful spinal metastases. A total of 158 patients from 33 hospitals will be enrolled in Japan over 3.5 years. This trial has been registered in the Japan Registry of Clinical Trials as jRCTs1030240172 (https://jrct.niph.go.jp/latest-detail/jRCT1030240172).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Japan Clinical Oncology Group Data Center/Operations Office, National Cancer Center Hospital, Tokyo, Japan.
- Division of Radiation Oncology, Department of Radiology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
- Department of Radiation Oncology, St. Marianna University School of Medicine, Kanagawa, Japan.
- Department of Radiological Sciences, Komazawa University, Tokyo, Japan.
- Division of Integrative Medical Oncology, Saiseikai Kumamoto Hospital, Kumamoto, Japan.
- Department of Radiation Oncology, Graduate School of Biomedical Health Sciences, Hiroshima University, Hiroshima, Japan.
ORCID-Profile: Ryosuke Kita, Kei Ito, Yuta Sekino, Takashi Mizowaki
Förderung
- National Cancer Center Research and Development Funds
Zitieren
APA
Kita, R., Ito, K., Machida, R., Sekino, Y., Nakamura, N., Nakajima, Y., Saito, T., Imano, N., Fukuda, H., Ito, Y., Mizowaki, T., & Japan Clinical Oncology Group Radiation Therapy Study Group (2025). Randomized phase III study comparing re-irradiation stereotactic body radiotherapy and conventional radiotherapy for painful spinal metastases: Japan Clinical Oncology Group study JCOG2211 (RESCORE study). Japanese Journal of Clinical Oncology. https://doi.org/10.1093/jjco/hyae145
Vancouver
Kita R, Ito K, Machida R, Sekino Y, Nakamura N, Nakajima Y, et al. Randomized phase III study comparing re-irradiation stereotactic body radiotherapy and conventional radiotherapy for painful spinal metastases: Japan Clinical Oncology Group study JCOG2211 (RESCORE study). Japanese Journal of Clinical Oncology. 2025. doi:10.1093/jjco/hyae145
BibTeX
@article{Kita2025,
author = {Kita, Ryosuke and Ito, Kei and Machida, Ryunosuke and Sekino, Yuta and Nakamura, Naoki and Nakajima, Yujiro and Saito, Tetsuo and Imano, Nobuki and Fukuda, Haruhiko and Ito, Yoshinori and Mizowaki, Takashi and Japan Clinical Oncology Group Radiation Therapy Study Group, Japan Clinical Oncology Group Radiation Therapy Study Group},
title = {Randomized phase III study comparing re-irradiation stereotactic body radiotherapy and conventional radiotherapy for painful spinal metastases: Japan Clinical Oncology Group study JCOG2211 (RESCORE study)},
journal = {Japanese Journal of Clinical Oncology},
year = {2025},
doi = {10.1093/jjco/hyae145}
}
EUVIMED